Centers For Disease Control And Prevention
Clinical trials sponsored by Centers For Disease Control And Prevention, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Needle-Free rotavirus vaccine patch enters first human tests Results expected Oct 2026 (estimated)
- Could TB treatment be cut from 6 months to 17 weeks? Results expected Dec 2026 (estimated)
-
Needle-Free rotavirus vaccine patch enters first human tests
Vaccine OngoingThis early-stage study is testing a new rotavirus vaccine that is given through a dissolving microneedle patch on the skin, instead of a shot. The trial will enroll 50 healthy adults aged 18 to 45 to see if the vaccine is safe and whether it triggers an immune response. Participa…
Phase 1 • Sponsor: Centers for Disease Control and Prevention • Aim: Vaccine
Last updated Jun 27, 2026 09:10 UTC
-
Could TB treatment be cut from 6 months to 17 weeks?
Disease control OngoingThis study tests whether two new 17-week drug combinations can treat pulmonary tuberculosis as effectively as the standard 6-month regimen. About 288 people with TB will receive one of three daily pill regimens. The goal is to see if shorter treatment can clear the infection fast…
Phase 2/3 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Sep 22, 2026 00:00 UTC
-
Caregiver support study canceled before it began
Knowledge-focused CancelledThis study was designed to test a program that helps caregivers of people with traumatic brain injury improve their problem-solving skills. It planned to enroll adults aged 19 and older, but was withdrawn before any participants joined, so no results are available.
Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC